NCT04400357View on ClinicalTrials.gov

Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors

NAUnknownINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

October 7, 2022

Study Completion Date

November 30, 2022

Conditions
Pancreatic AdenocarcinomaPancreatic CystsPancreatic Endocrine TumorsChronic PancreatitisCholangiocarcinoma, ExtrahepaticAmpullary AdenocarcinomaDuodenal Adenocarcinoma
Interventions
PROCEDURE

Robotic pancreaticoduodenectomy

Patients in this arm will undergo a pancreaticoduodenectomy with robotic-assisted techonology.

PROCEDURE

Open pancreaticoduodenectomy

Patients in this arm will undergo an open pancreaticoduodenectomy which is the standard surgical approach.

Trial Locations (1)

200025

RECRUITING

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

Sponsors

Collaborators (1)

Intuitive Surgical
All Listed Sponsors
collaborator

Intuitive Surgical

INDUSTRY

lead

Ruijin Hospital

OTHER

NCT04400357 - Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors | Biotech Hunter | Biotech Hunter